Satellos Bioscience (MSLE) Non-Current Assets (2023 - 2026)
Satellos Bioscience's (MSLE) quarterly Non-Current Assets came in at $8000.0 in Q1 2026, up 60.0% on a QoQ basis from $5000.0 in Q4 2025.
Satellos Bioscience (MSLE) Non-Current Assets (2023 - 2026) Analysis & Trends
Satellos Bioscience (MSLE) has 4 years of Non-Current Assets data on file, last reported at $8000.0 in Q1 2026.
- On a quarterly basis, Non-Current Assets changed N/A year-over-year to $8000.0 in Q1 2026; TTM through Mar 2026 was $2.9 million, a N/A change from a year earlier, with the FY2025 full-year figure at $5000.0, up 39.69% from the prior year.
- Non-Current Assets for Q1 2026 stood at $8000.0, up from $5000.0 in the prior quarter.
- Over the last five years, Non-Current Assets for MSLE reached as high as $2.9 million in Q4 2023 and fell as low as $3579.2 in Q4 2024.
- Historically, Non-Current Assets has averaged $734273.1 across 4 years, with a median of $6500.0 in 2025.
- Across the five-year window, Non-Current Assets sank 99.88% in 2024 and jumped 39.69% in 2025, its largest moves.
- Year by year, Non-Current Assets stood at $2.9 million in 2023, then sank by 99.88% to $3579.2 in 2024, then surged by 39.69% to $5000.0 in 2025, then surged by 60.0% to $8000.0 in 2026.
- Per Business Quant data, the three most recent Non-Current Assets figures were $8000.0 in Q1 2026, $5000.0 in Q4 2025, and $3579.2 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 21.65 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 5.83 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.95 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 3.95 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.75 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.66 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.96 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 285.82 Mn |
| 10 | Satellos Bioscience | 148.71 Mn | 148.71 Mn | - | 8,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8,000.00 |
| Dec 31, 2025 | 5,000.00 |
| Dec 31, 2024 | 3,579.25 |
| Dec 31, 2023 | 2.92 Mn |